Price cut causes Invokana withdrawal


"diabetes" in coloured text

Janssen-Cilag has removed INVOKANA (canagliflozin) from the PBS effective from 1 August 2015. The company was requested by the Department of Health, to either take a significant price reduction of close to 40% on Invokana, or face the medicine being removed from the PBS.



This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?

Previous Rogue drug sellers or online pharmacies?
Next Interest rate cut good news for pharmacy

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.